Company record
Undecimal Bio
Updated October 24, 2026 · Presspool
Undecimal pairs massive scale combinatorial chemistry with transformer-based AI to guide siRNA therapeutics into the tissues that need them. undecimalbio.com
Funding
- $18 million Seed, announced October 13, 2026. Led by 4BIO Capital and IQ Capital. EU-Startups reported the round as €16 million; Verve Ventures, Harel Tech, Entrée Capital, Kerna Ventures and Saras Capital participated. Listed in the AI startup funding roster for October 12–17, 2026. Sources: Ctech, EU-Startups.
Of the 84 Seed rounds with exactly stated amounts in dollars on Presspool's weekly rosters since September 21, 2026, Undecimal Bio's $18 million is the 13th largest; their median is $7.2 million.
Whether AI names Undecimal Bio
- Machine Relations Index: Not cited in any Machine Relations Index answer, May 10, 2026 to October 24, 2026.
Related records
Closest rounds in the roster for October 12–17, 2026: Causa Prima ($20 million Seed, October 13, 2026), Ubitium ($14 million Seed, October 13, 2026), Harbor ($10 million Seed, October 13, 2026), Forgepoint ($9.8 million Seed, October 14, 2026), Othello ($8 million Seed, October 14, 2026), Uvi ($7.5 million Seed, October 14, 2026).
Entrée Capital, named as an investor in this round, led Chamelio ($26 million Series A, September 22, 2026). It is also named as an investor in Ultra Security ($10 million Seed, October 21, 2026).